These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9148535)
21. Venous thrombosis: prevalence of prothrombotic defects in north Indian population. Bhattacharyya M; Kannan M; Chaudhry VP; Saxena R Indian J Pathol Microbiol; 2003 Oct; 46(4):621-4. PubMed ID: 15025358 [TBL] [Abstract][Full Text] [Related]
22. [A test for APC resistance prior to prescription of oral contraceptives? Discussion about screening should be based on facts]. Dahlbäck B Lakartidningen; 1995 Nov; 92(48):4558, 4561. PubMed ID: 7490973 [No Abstract] [Full Text] [Related]
23. Haemostatic changes and acquired activated protein C resistance in normal pregnancy. Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957 [TBL] [Abstract][Full Text] [Related]
24. Congenital and acquired activated protein C resistance. Nicolaes GA; Dahlbäck B Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491 [TBL] [Abstract][Full Text] [Related]
25. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation. De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766 [TBL] [Abstract][Full Text] [Related]
26. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients. Eid SS Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777 [TBL] [Abstract][Full Text] [Related]
27. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia. Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850 [TBL] [Abstract][Full Text] [Related]
28. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain. Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991 [TBL] [Abstract][Full Text] [Related]
29. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075 [TBL] [Abstract][Full Text] [Related]
30. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis]. Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836 [TBL] [Abstract][Full Text] [Related]
31. Low level of circulating activated protein C is a risk factor for venous thromboembolism. España F; Vayá A; Mira Y; Medina P; Estellés A; Villa P; Falcó C; Aznar J Thromb Haemost; 2001 Dec; 86(6):1368-73. PubMed ID: 11776301 [TBL] [Abstract][Full Text] [Related]
32. [Activated protein C resistance--a recently discovered hereditary thrombophilia]. Moland L; Sandset PM Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002 [TBL] [Abstract][Full Text] [Related]
33. [General anticoagulant factor deficiency related to venous thrombosis has been identified]. Syrjälä M Duodecim; 1994; 110(14):1307-9. PubMed ID: 7497943 [No Abstract] [Full Text] [Related]
34. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members. Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804 [TBL] [Abstract][Full Text] [Related]
35. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652 [TBL] [Abstract][Full Text] [Related]
36. [Post-phlebitic leg ulcers and XYY karyotype: fibrinolysis and androgenic function tests. Apropos of 3 cases]. Bennet A; Caron P; Sie P; Louvet JP; Bazex J Ann Dermatol Venereol; 1987; 114(9):1097-101. PubMed ID: 3434947 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy]. Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of phenotypic activated protein C resistance (APCR) in venous thromboembolic patients. Marzo C; Araguás C; Gómez-Arbonés J; Ramírez S Haematologica; 1998 Apr; 83(4):377-8. PubMed ID: 9592990 [TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis. Gessoni G; Valverde S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946 [TBL] [Abstract][Full Text] [Related]
40. Patients with AT III, protein C or protein S defects show no associated hereditary APC-resistance. Simioni P; Prandoni P; Girolami A Thromb Haemost; 1994 Sep; 72(3):481-2. PubMed ID: 7855802 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]